by FiveSenses | Sep 25, 2023 | News Release
Vancouver, BC, Canada, September 25th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that its... 
by FiveSenses | Sep 25, 2023 | News Release
Vancouver, BC, Canada, September 22nd, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce it has... 
by FiveSenses | Sep 12, 2023 | News Release
Vancouver, BC, Canada, September 12th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), one of the leading Canadian biotechnology companies, is pleased to announce its continuation to bringing innovative strategies aimed at targeting various... 
by FiveSenses | Sep 5, 2023 | News Release
Vancouver, BC, Canada, September 5, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce that Viewpoint, the educational... 
by FiveSenses | Jul 4, 2023 | News Release
Vancouver, BC, Canada, July 4, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies is pleased to announce its collaboration with Viewpoint...
Recent Comments